FDA clears Telix's Pixclara as the world's first approved brain cancer imaging drug

The FDA has approved Telix Pharmaceuticals' Pixclara, the first brain cancer imaging drug for glioma, enabling improved diagnosis and treatment planning in the U.S. This approval opens the market to FET PET imaging in brain cancer diagnostics for the first time domestically.

This Wire brief sits within Fusion42's coverage of Medtech, and 5 sources have reported it.